01-04-2024 | Vulgar Psoriasis | Case report
Pembrolizumab/Prednisolone
Psoriasis and rebound effect in the form of exacerbation of the cutaneous rash and pruritus.
Published in: Reactions Weekly | Issue 1/2024
Login to get accessExcerpt
Author Information-
* death
-
* life-threatening
-
* hospitalisation
-
* disability
-
* congenital anomaly
-
* other medically important event